Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment for Drug-Resistant Gonorrhea Following Successful Phase 3 Clinical Trials May 28, 2026 Susilo Ahmad Researchers are poised to revolutionize the treatment landscape for gonorrhea with the successful completion of a late-stage phase 3 clinical trial for a novel oral medication, zoliflodacin. Published in the…
Sexual Health & Medical Wellness Zoliflodacin Shows Promise as Single-Dose Oral Treatment for Gonorrhea, Offering New Hope Against Rising Antibiotic Resistance March 28, 2026 Susilo Ahmad In a significant development for global public health, researchers have unveiled compelling results from a late-stage Phase 3 clinical trial for zoliflodacin, a novel oral medication designed to combat gonorrhea.…
